Intensive
[대역어] 철저한
[용어속성] Term
[용어속성] Term
Surgical Triage and Timing for Patients With Coronavirus Disease: A Guidance Statement from The Society of Thoracic Surgeons
코로나바이러스 질환 환자의 외과적 분류 및 시기: 흉부외과학회의 지침서
Article
[키워드] acute respiratory syndrome
Algorithm
angiography
cardiac
Cardiology
cardiovascular
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 case
COVID-19 cases
Critical care
diagnosed with COVID-19
disrupt
Guidance
Intensive
Intervention
likelihood
offer
outcome
pandemic
Patient
perioperative period
public health
Society
STS
surgery
surgical
Triage
Vaccines
variant
Vascular surgery
widespread
[DOI] 10.1016/j.athoracsur.2022.05.001 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.athoracsur.2022.05.001 PMC 바로가기 [Article Type] Article
Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy
Review article
[키워드] ACE2angiotensin converting enzyme 2
acute lung injury
acute respiratory distress syndrome
adverse outcome
ALIacute lung injury
alveolar type 2 cells
angiotensin converting enzyme 2
ARDSacute respiratory distress syndrome
AstraZeneca
AT2salveolar type 2 cells
ataxia telangiectasia and Rad3-related
ATRataxia telangiectasia and Rad3-related
BDNFbrain derived neurotrophic factor
brain derived neurotrophic factor
BRDbromodomain protein
bromodomain protein
C-reactive protein
CCNG1Cyclin G1
CD147cluster of differentiation 147
Cell
Clinical finding
cluster of differentiation 147
confirmed case
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
COVID-19 patients
COVID-19coronavirus disease 2019
CRPC-reactive protein
Cyclin G1
Cytokine storm
DRP1dynamin-related protein 1
dynamin-related protein 1
ECMOextracorporeal membrane oxygenation
effective
EGFepidermal growth factor
Emergency use authorization
epidermal growth factor
EUAemergency use authorization
EVsextracellular vesicles
example
exhibited
Extracellular vesicles
extracorporeal membrane oxygenation
FGFfibroblast growth factor
fibroblast growth factor
galanin and gmap prepropeptide
GALgalanin and gmap prepropeptide
GM-CSFgranulocyte macrophage-colony stimulating factor
granulocyte macrophage-colony stimulating factor
HBVHepatitis B virus
Heme oxygenase-1
Hepatitis B virus
hepatocyte growth factor
hESCshuman embryonic stem cells
HGFhepatocyte growth factor
hiPSCshuman induced PSCs
HIVhuman immunodeficiency virus
HO-1heme oxygenase-1
hPSC-CMshPSC-derived cardiomyocytes
hPSC-derived cardiomyocytes
hPSCshuman pluripotent stem cells
human embryonic stem cells
Human immunodeficiency virus
human induced PSCs
human pluripotent stem cells
Hyperinflammatory syndrome
IFN-βinterferon-β
IFN-γinterferon-γ
IFN-λinterferon-λ
IGF1Rinsulin like growth factor 1 receptor
Infection
insulin like growth factor 1 receptor
Intensive
Interferon-β
interferon-γ
interferon-λ
keratinocyte growth factor-2
KGF2keratinocyte growth factor-2
leukemia inhibitory factor
LIFleukemia inhibitory factor
management
MECP2methyl-CpG binding protein 2
Mesenchymal stem cells
methyl-CpG binding protein 2
Microvesicles
Moderna
Mortality
MSCs
MSCs therapy
MSCsmesenchymal stem cells
MVsmicrovesicles
National Institutes of Health
nerve growth factor
NGFnerve growth factor
NIHNational Institutes of Health
nitric oxide associated 1
NLR family pyrin domain containing 3
NLRP3NLR family pyrin domain containing 3
NOA1nitric oxide associated 1
organ damage
organ injury
P4HA1prolyl 4-hydroxylase subunit alpha 1
PDGFplatelet-derived growth factor
Pfizer
PGE2prostaglandin E2
phosphatase and tensin homolog
platelet-derived growth factor
Preclinical
Preferred reporting items for systematic reviews and meta-analyses
PRISMAPreferred reporting items for systematic reviews and meta-analyses
proinflammatory
prolyl 4-hydroxylase subunit alpha 1
prostaglandin E2
PTENphosphatase and tensin homolog
Pulmonary infection
Randomized controlled trial
RCTrandomized controlled trial
S-proteinspike protein
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
SEMA3Asemaphorin 3 A
semaphorin 3 A
severe acute respiratory syndrome coronavirus 2
sialyl Lewis X
signal transducer and activator of transcription 3
SLeXsialyl Lewis X
Spike protein
spread of COVID-19
STAT3signal transducer and activator of transcription 3
stem cell
TGF-β1transforming growth factor β1
TGFBR1transforming growth factor β receptor I
Therapies
therapy
tissue regeneration
TLR4toll-like receptors 4
TMPRSS2transmembrane protease serine protease 2
TNFTumor Necrosis Factor
toll-like receptors 4
transforming growth factor β receptor I
transforming growth factor β1
transmembrane protease serine protease 2
tumor necrosis factor
utility
Vaccine
Vaccines
vascular cell adhesion molecule
vascular endothelial growth factor
VCAMvascular cell adhesion molecule
VEGFvascular endothelial growth factor
[DOI] 10.1016/j.phrs.2022.106334 [Article Type] Review article
[DOI] 10.1016/j.phrs.2022.106334 [Article Type] Review article
The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials
병원 내 사망 위험이 높은 환자의 생존에 대한 레파릭신의 효과: 무작위 시험의 메타 분석
Meta-Analysis
[키워드] 95% confidence interval
addition
all-cause mortality
antagonist
anti-inflammatory drug
Anti-inflammatory drugs
article
CENTRAL
Chemokine receptor
comparator
control group
Controlled
controlled trials
COVID-19
Critical
Critical care
CXCL-8
CXCL8
CXCR1
CXCR2
CXCR2 antagonist
heterogeneity
high risk
identify
IL-8
In-hospital
in-hospital mortality
include
independent
Infection
inhibitor
Intensive
intensive &
involved
Meta-analysis
no difference
Odds ratio
P -value
Patient
patients
performed
Pneumonia
Randomized controlled trial
Randomized controlled trials
randomized trial
randomized trials
RCT
RCTs
receptor
receptors
Reparixin
risk of bia
risk of infection
RoB 2
SARS-CoV-2
SARS-COV-2 infection
screened
searched
Sepsis
shown
significantly lower
suggested
survival
Treatment
trials
two groups
was used
[DOI] 10.3389/fimmu.2022.932251 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.3389/fimmu.2022.932251 PMC 바로가기 [Article Type] Meta-Analysis
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort
대규모 용도 변경 노력에서 VERO-E6 세포에 대한 세포변성 SARS-CoV-2 스크리닝
Article
[키워드] accelerate
anti-inflammatory drug
approach
Cell
Compound
COVID-19
COVID-19 disease
Dexamethasone
Drug discovery
drugs
effective
effort
greater
highlighting
idea
identify
inhibitor
Intensive
mechanism
Patient
patients
phenotypic
phenotypic screening
potential therapies
potential therapy
reducing mortality
Remdesivir
repertoire
Repurposed drug
Repurposed drugs
SARS-CoV-2
SARS-COV-2 infection
screened
shown
Support
Time to recovery
viral infection
[DOI] 10.1038/s41597-022-01532-x PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41597-022-01532-x PMC 바로가기 [Article Type] Article
Maintaining the Partnership Between a Tribal Breast and Cervical Cancer Program and a University-Based Cancer Prevention Center During COVID-19 Lock-Down Restrictions-A Case Study
Article
[키워드] addressed
adhere
age
Breast
build
Cancer
cancer diagnosis
Care
center
Cervical
Community
connection
COVID-19
COVID-19 pandemic
COVID-19 virus
develop
face-to-face interaction
facilitate
Health
IMPROVE
Intensive
Interaction
Internet
maintain
maintaining
measure
modify
nation
National Cancer Institute
Native
Native Americans
Navajo
Navajo Nation
pandemic
partnership
partnership building
physical distancing
platform
podcast.
prevention
Program
recommendation
required
Screening
social interaction
Spread
Stress
Support
survival
Travel
Treatment
university
virus
women
[DOI] 10.3389/fpubh.2022.902253 PMC 바로가기
[DOI] 10.3389/fpubh.2022.902253 PMC 바로가기
ISW-LM: An intensive symptom weight learning mechanism for early COVID-19 diagnosis
Research article
[키워드] Analysis
blood test
Characteristics
classification
clinician
Comorbidities
cough
country
COVID-19
COVID-19 diagnosis
COVID-19 infection symptom
dataset
datasets
diagnose
diagnosing
Diagnosis
Diagnostic method
early diagnosis
early stage
Efficiency
epidemiological
experiment
Fever
function
help
high accuracy
identify
impacted
Intensive
Isolation
Laboratory
learning
Learning mechanism
machine learning models
mechanism
novel coronavirus disease
outcome
pandemic
Patient
patients
performed
positive result
Predictive
regions
Self-isolation
sore throat
Spread
Symptom
Symptom weight
Symptoms
trajectory
Treatment
virus
weight
[DOI] 10.1016/j.compbiomed.2022.105615 [Article Type] Research article
[DOI] 10.1016/j.compbiomed.2022.105615 [Article Type] Research article
Human Factors and Ergonomics (HFE) applications in responses to the COVID-19 pandemic: Lessons learned and considerations for methods
Research article
[키워드] 1. COVID-19
2. HFE in Public health crises
3. SEIPS
applied
change
congress
contribute
COVID-19
COVID-19 pandemic
develop
diagnostic
ENhance
ergonomics
expand
Factor
faster
HFE
Human
Intensive
less
lesson
methodological
Pain
resource
response
Support
[DOI] 10.1016/j.apergo.2022.103733 [Article Type] Research article
[DOI] 10.1016/j.apergo.2022.103733 [Article Type] Research article
Patients Surviving Critical COVID-19 have Impairments in Dual-task Performance Related to Post-intensive Care Syndrome
Observational Study
[키워드] 6MWT
battery
Care
ceiling effect
CLD
cognitive
construct validity
control group
COVID-19
COVID-19 group
Critical
cross-sectional
demonstrated
detectable
determine
gait speed
hospital discharge
Hospitalization
impairment
Intensive
intensive care
Lung disease
maintain
mDC
measurement
mechanical ventilation
minute
Mobility
Older age
Patient
performance
performed
physical
Physical function
post intensive care syndrome.
Prospective
psychometric property
recovering from COVID-19
repeated
required
returned
significantly
subset
supplemental oxygen
survivor
syndrome
Test
United States
[DOI] 10.1177/08850666221075568 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1177/08850666221075568 PMC 바로가기 [Article Type] Observational Study
Factors associated with, and variations in, COVID-19 hospital death rates in England’s first two waves: observational study
Observational Study
[키워드] accounted
adjusted
Admission
adult intensive &
Care
Comorbidities
correlation
COVID-19
COVID-19 admission
Critical
Critical care
death
death rate
death rates
diagnosis of COVID-19
England
Factor
Factors
Health
hospital
Hospital Episode Statistics
hypertension
Intensive
Length
limits
median
moderate
mortality rate
obesity
observational study
Odds ratio
outlier
Patient
peaked
predictor
Quality
quality in health care
random
second wave
significantly
variable
Variation
Wave
[DOI] 10.1136/bmjopen-2021-060251 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1136/bmjopen-2021-060251 PMC 바로가기 [Article Type] Observational Study